Predicted protein targets (top 20)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | MAPT | P10636 | 3/20 | 0.47 |
| ▸ | POLB | P06746 | 1/20 | 0.47 |
| ▸ | GAA | P10253 | 1/20 | 0.47 |
| ▸ | SMN1; SMN2 | Q16637 | 1/20 | 0.42 |
| ▸ | TSHR | P16473 | 3/20 | 0.40 |
| ▸ | HSD17B10 | Q99714 | 2/20 | 0.40 |
| ▸ | LMNA | P02545 | 1/20 | 0.40 |
| ▸ | KDM4E | B2RXH2 | 1/20 | 0.40 |
| ▸ | HTT | P42858 | 1/20 | 0.40 |
| ▸ | ALDH1A1 | P00352 | 4/20 | 0.39 |
| ▸ | MEN1 | O00255 | 2/20 | 0.39 |
| ▸ | KMT2A | Q03164 | 2/20 | 0.39 |
| ▸ | HPGD | P15428 | 3/20 | 0.39 |
| ▸ | RAB9A | P51151 | 2/20 | 0.39 |
| ▸ | CYP1A2 | P05177 | 1/20 | 0.39 |
| ▸ | CYP3A4 | P08684 | 1/20 | 0.39 |
| ▸ | CYP2D6 | P10635 | 1/20 | 0.39 |
| ▸ | CYP2C19 | P33261 | 1/20 | 0.39 |
| ▸ | NPC1 | O15118 | 1/20 | 0.39 |
| ▸ | HCAR2 | Q8TDS4 | 1/20 | 0.38 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL930295 | 0.98 | MAPT (0.46) | MAPTPOLBGAASMN1; SMN2TSHR | |
| SCHEMBL663162 | 0.98 | MAPT (0.46) | MAPTPOLBGAASMN1; SMN2TSHR | |
| SCHEMBL7122480 | 0.95 | MAPT (0.44) | MAPTPOLBGAASMN1; SMN2TSHR | |
| SCHEMBL8133890 | 0.95 | — | — | |
| SCHEMBL28794480 | 0.91 | MAPT (0.42) | MAPTPOLBGAASMN1; SMN2TSHR | |
| SCHEMBL497608 | 0.90 | — | — | |
| SCHEMBL28657261 | 0.88 | MAPT (0.40) | MAPTPOLBGAASMN1; SMN2TSHR | |
| Hydrochloric Acid SCHEMBL11286601 | 0.87 | — | — | |
| Acetic Acid SCHEMBL11173187 | 0.84 | BRD4 (0.47) | MAPTPOLBGAASMN1; SMN2TSHR | |
| Methylamine SCHEMBL28610020 | 0.83 | MAPT (0.46) | MAPTPOLBGAASMN1; SMN2TSHR |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 453 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| EP-4362916-A1 | AQUEOUS GEL COMPOSITION | Acousia Therapeutics GmbH (DE) | 2024-05-08 | — | — | EP | claimed |
| CN-117881393-A | Aqueous gel composition | 阿库西亚医疗有限责任公司 | 2024-04-12 | — | — | CN | claimed |
| WO-2023222795-A1 | AQUEOUS GEL COMPOSITION | ACOUSIA THERAPEUTICS GMBH (DE) | 2023-11-23 | — | — | WO | claimed |
| EP-4279061-A1 | AQUEOUS GEL COMPOSITION | Acousia Therapeutics GmbH (DE) | 2023-11-22 | — | — | EP | claimed |
| US-11548906-B2 | Processes for the preparation of SGLT-2 inhibitors, intermediates thereof | EMMENNAR PHARMA PRIVATE LIMITED (IN) | 2023-01-10 | — | — | US | claimed |
| CN-110635045-B | Water/alcohol soluble organic solar cell anode modification layer material and preparation method thereof | 南昌航空大学 | 2022-08-19 | — | — | CN | claimed |
| CN-114799615-A | Silver powder surface modification method, silver solder paste, and preparation method and application of silver solder paste | 深圳先进电子材料国际创新研究院 | 2022-07-29 | — | — | CN | claimed |
| CN-113387964-A | Cyclopentathiophene organic micromolecule photovoltaic material and preparation method and application thereof | 华南理工大学 | 2021-09-14 | — | — | CN | claimed |
| US-10913762-B2 | Process for the preparation of D-glucitol, 1,5-anhydro-1-C-[4-chloro-3-[[4-[[(3S)-tetrahydro-3-furanyl] oxy]phenyl] methyl] phenyl]-, (1S) and its crystalline forms thereof | MSN LABORATORIES PRIVATE LIMITED (IN) | 2021-02-09 | — | — | US | claimed |
| US-20200331946-A1 | PROCESSES FOR THE PREPARATION OF SGLT-2 INHIBITORS, INTERMEDIATES THEREOF | EMMENNAR PHARMA PRIVATE LIMITED, (IN) | 2020-10-22 | — | — | US | claimed |
| EP-0560055-B1 | Immuno-suppressing enepyranose derivatives | ISHIHARA SANGYO KAISHA (JP) | 2002-08-28 | — | — | EP | claimed |
| EP-0465913-B1 | Diaminotrifluoromethylpyrimidine derivatives, process for their production and phospholipase A2 inhibitor containing them | ISHIHARA SANGYO KAISHA (JP) | 1997-09-10 | — | — | EP | claimed |
| US-5492908-A | ANTIARTHRITIC | ISHIHARA SANGYO KAISHA LTD. (JP) | 1996-02-20 | — | — | US | claimed |
| US-5348967-A | Diaminotrifluoromethylpyridine derivatives, process for their production and phospholipase A2 inhibitor containing them | ISHIHARA SANGYO KAISHA LTD. (JP) | 1994-09-20 | — | — | US | claimed |
| US-5304657-A | Insecticides | ISHIHARA SANGYO KAISHA LTD. (JP) | 1994-04-19 | — | — | US | claimed |
| EP-0483647-A1 | Hydrazine compounds or their salts, processes for producing them and pesticides containing them | ISHIHARA SANGYO KAISHA, LTD. (JP) | 1992-05-06 | — | — | EP | claimed |
| EP-0465913-A2 | Diaminotrifluoromethylpyrimidine derivatives, process for their production and phospholipase A2 inhibitor containing them | ISHIHARA SANGYO KAISHA, LTD. (JP) | 1992-01-15 | — | — | EP | claimed |
| US-4235938-A | AUGMENTING BACON OR CARMEL FLAVOR | INTERNATIONAL FLAVORS & FRAGRANCES INC. (US) | 1980-11-25 | — | — | US | claimed |
| US-4005138-A | REACTION OF DISULFIDES OR MERCAPTANS WITH NITROGEN OXIDES AND HYDROGEN FLUORIDE | CIBA-GEIGY CORPORATION (US) | 1977-01-25 | — | — | US | claimed |
| US-3966988-A | Flavoring compositions and processes utilizing dithiazine compounds | INTERNATIONAL FLAVORS & FRAGRANCES INC. (US) | 1976-06-29 | — | — | US | claimed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (3 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-11548906-B2 | Processes for the preparation of SGLT-2 inhibitors, intermediates thereof | SLC5A2, SLC5A1, SLC2A4 | MAPT 340/4885POLB 4657/4885GAA 147/4885 |
| US-10913762-B2 | Process for the preparation of D-glucitol, 1,5-anhydro-1-C-[4-chloro-3-[[4-[[(3S)-tetrahydro-3-furanyl] oxy]phenyl] methyl] phenyl]-, (1S) and its crystalline forms thereof | ALG1, FBP1, DAD1 | MAPT 2138/4885POLB 3632/4885GAA 516/4885 |
| US-20200331946-A1 | PROCESSES FOR THE PREPARATION OF SGLT-2 INHIBITORS, INTERMEDIATES THEREOF | SLC5A2, SLC5A1, SLC2A4 | MAPT 340/4885POLB 4657/4885GAA 147/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.